New stem cell transplant could help more blood cancer patients find a donor
NCT ID NCT06225050
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new way to do stem cell transplants for adults with high-risk blood cancers who don't have a fully matched donor. Doctors will use stem cells from a half-matched (haploidentical) donor and remove certain immune cells to try to prevent severe graft-versus-host disease, a serious side effect. The goal is to see if this method is safe and effective for 18 participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGICAL MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple blood test outsmart deadly fungal infections in blood cancer?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Can a safer dose of an old drug shield vulnerable children from deadly fungal infections?
- Can a lower drug dose make stem cell transplants safer?
- Plant pigment could soothe Radiation's harsh side effect in blood cancer treatment
- New Antibody-Drug conjugate targets Hard-to-Treat cancers